Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04765605 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 25, 2025 to Dec 25, 2026v3
  2. Primary completion date: Apr 25, 2022 to Dec 25, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Apr 15, 2023 to Dec 25, 2025
    • Site details revised at 29 of 29 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a prospective, multiple center study to evaluate the safety and effectiveness of WeFlow-Tbranch single embedded branch thoracic aorta stent graft system manufactured by EndoNom Medtech (Hangzhou) Co., Ltd.
Trial Details
NCT Number NCT04765605
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions
(from sponsor)		 Type B Aortic Dissection
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov